Hexagons on blue gradient background

Fierce Biotech 2025

San Francisco, United States | 14 January 2025 - 15 January 2025
Overview

Connect with us at Fierce Biotech 2025 this January

At Fierce JPM Week 2025, industry leaders will come together to explore what’s next. From market analysis to an examination of evolving regulatory landscapes, this event will provide expert insights into the opportunities and pressing challenges shaping the future of pharma, biotech, and healthcare.

fierce biotech cro award finalist 2024

 

If you are planning on attending, schedule a partnering meeting with Quotient Sciences to talk one-on-one about your drug development needs.

Jamie Weishaar, VP, Global Commercial Drug Product will be at this event and is ready to hear about your drug program's challenges and discuss how Quotient Sciences can assist in accelerating your drug development timeline with our integrated approach.  Learn how our capabilities are fully integrated with our global drug product and clinical testing capabilities to streamline your program. Our seamless integration of services has been proven to reduce at least 12 months of development time and substantially reduce R&D costs.

You can schedule a partnering meeting with us through the form below.  
 

Request
Location
Hyatt Regency
5 Embarcadero Center , CA 94111
San Francisco, United States

Meet our expert

We look forward to meeting you at Fierce Biotech 2025 in San Francisco this January

Jamie Weishaar

Global Commercial Lead, Drug Product

Jamie is an experienced Business Development Executive leader specializing in Pharmaceutical Drug Development, including Contract ...

Contact Us

More insight from our experts:

Read More
Drug Product, Integrated Programs, Dr. Asma Patel Accelerated pathways and CMC challenges in rare disease drug development By: Dr. Asma Patel
Read More
Drug Product, Drug Substance, Translational Pharmaceutics, Thierry Van Nieuwenhove Interview with Thierry Van Nieuwenhove: On Quotient Sciences' Growth and Role in Accelerating Drug Development By: Thierry Van Nieuwenhove
Read More